- Home
- ISPR vs BHST Comparison
ISPR vs BHST Comparison
Compare ISPR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- BHST
- Stock Information
- Founded
- ISPR 2019
- BHST 2007
- Country
- ISPR United States
- BHST Canada
- Employees
- ISPR N/A
- BHST N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- BHST
- Sector
- ISPR Health Care
- BHST
- Exchange
- ISPR Nasdaq
- BHST Nasdaq
- Market Cap
- ISPR 152.0M
- BHST 166.4M
- IPO Year
- ISPR 2023
- BHST N/A
- Fundamental
- Price
- ISPR $3.06
- BHST $8.18
- Analyst Decision
- ISPR Strong Buy
- BHST Strong Buy
- Analyst Count
- ISPR 2
- BHST 2
- Target Price
- ISPR $10.00
- BHST $13.00
- AVG Volume (30 Days)
- ISPR 47.6K
- BHST 21.1K
- Earning Date
- ISPR 09-19-2025
- BHST 08-11-2025
- Dividend Yield
- ISPR N/A
- BHST N/A
- EPS Growth
- ISPR N/A
- BHST N/A
- EPS
- ISPR N/A
- BHST N/A
- Revenue
- ISPR $144,700,345.00
- BHST $30,192,000.00
- Revenue This Year
- ISPR N/A
- BHST $116.40
- Revenue Next Year
- ISPR $35.39
- BHST $55.91
- P/E Ratio
- ISPR N/A
- BHST N/A
- Revenue Growth
- ISPR N/A
- BHST 57.83
- 52 Week Low
- ISPR $2.09
- BHST $4.66
- 52 Week High
- ISPR $7.79
- BHST $9.90
- Technical
- Relative Strength Index (RSI)
- ISPR 66.49
- BHST 47.70
- Support Level
- ISPR $2.74
- BHST $7.65
- Resistance Level
- ISPR $3.43
- BHST $9.45
- Average True Range (ATR)
- ISPR 0.19
- BHST 0.67
- MACD
- ISPR 0.05
- BHST -0.17
- Stochastic Oscillator
- ISPR 82.67
- BHST 23.58
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About BHST BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.